Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00351104 · ClinicalTrials.gov registry record · Phase 3
Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain
A Phase 3 study of Sprain and Strain, sponsored by APR Applied Pharma Research s.a..
- Completed
- Registry status
- Phase 3
- Development phase
- 200
- Enrollment target
- 1
- Study location
NCT00351104: Completed Phase 3 study of Sprain and Strain, sponsored by APR Applied Pharma Research s.a..
NCT00351104 is a Phase 3 study of Sprain and Strain that has completed, run by APR Applied Pharma Research s.a.. The registered enrollment target is 200 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00351104, a Phase 3 study of Sprain and Strain, has completed, sponsored by APR Applied Pharma Research s.a..
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 200 participants
- Enrollment target
- 1
- Study location
Study Summary
The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with ankle sprain or strain.
Interventions
- DRUG Ketoprofen Topical Patch 20%
Study Locations (1)
Texas
- PPD - Austin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 200 participants |
| Start Date | 2006-06 |
| Est. Completion | 2007-03 |
| Phase | Phase 3 |
What the finished NCT00351104 record still lists
NCT00351104 is an interventional study that assigns participants to a tested intervention. The registered 200 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (74% lower).
The record links to 2 conditions, with Sprain appearing as the primary indexed condition, and to 1 intervention - of which Ketoprofen Topical Patch 20% is the first listed.
NCT00351104 reports a single indexed study location in Texas.
Frequently Asked Questions
What is clinical trial NCT00351104 about?
NCT00351104 is a clinical study titled "Efficacy and Safety of Ketoprofen Topical Patch 20% in the Treatment of Pain Associated With Ankle Sprain or Strain". The purpose of this study is to evaluate the effect of a ketoprofen topical patch on the pain associated with ankle sprain or strain.
What is the current status of trial NCT00351104?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 200 participants. The study started on 2006-06. Estimated completion is 2007-03.
What conditions does trial NCT00351104 study?
This clinical trial studies the following conditions: Sprain, Strain.
What interventions are being tested in trial NCT00351104?
The interventions under investigation include: Ketoprofen Topical Patch 20% (DRUG).
Who is sponsoring clinical trial NCT00351104?
This trial is sponsored by APR Applied Pharma Research s.a., which has 7 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00351104 being conducted?
This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00351104's enrollment target sits among peer trials
200 1353rd of 2000 higher than 613 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00107289 · 200 participants · Phase 2
Iodine I 131 Metaiodobenzylguanidine in Treating Patients With Recurrent, Progressive, or Refractory Neuroblastoma or Malignant Pheochromocytoma or Paraganglioma
- NCT00109174 · 200 participants · NA
MRS Measurement of Glutamate and GABA Metabolism in Brain
- NCT00177268 · 200 participants
Blood, Urine, and Tissue Collection for Cutaneous Lymphoma, Eczema, and Atopic Dermatitis Research
- NCT00493688 · 200 participants
A Study to Determine Whether Perioperative Energy Dynamics Correlates With Postoperative Outcomes
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia